Discontinued — last reported Q3 '23
Consolidated Edison Equity Method Investments decreased by 12.4% to $1.06B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.4%, from $1.14B to $1.06B. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows a downward trend with a -7.8% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.69B | $1.08B | $853.00M | $833.00M | $794.00M | $805.00M | $841.00M | $905.00M | $942.00M | $933.00M | $999.00M | $1.04B | $1.08B | $1.14B | $1.13B | $1.14B | $1.19B | $1.23B | $1.21B | $1.06B |
| QoQ Change | — | -36.1% | -20.9% | -2.3% | -4.7% | +1.4% | +4.5% | +7.6% | +4.1% | -1.0% | +7.1% | +4.2% | +3.8% | +5.1% | -0.9% | +0.9% | +4.4% | +3.6% | -1.3% | -12.4% |
| YoY Change | — | — | — | — | -53.0% | -25.3% | -1.4% | +8.6% | +18.6% | +15.9% | +18.8% | +15.0% | +14.8% | +21.8% | +12.7% | +9.1% | +9.7% | +8.2% | +7.7% | -6.4% |